ライフサイエンスコーパス: serum ferritin

1 ficant reduction was observed (P = 0.004) in serum ferritin.

2 y stable within subjects and correlated with serum ferritin.

3 decreased tissue iron stores, as measured by serum ferritin.

4 t consistently was inversely associated with serum ferritin.

5 e ratio of the serum transferrin receptor to serum ferritin.

6 absorbed iron was inversely associated with serum ferritin.

7 es between groups in adjusted mean height or serum ferritin.

8 eral flow immunoassay test strip to quantify serum ferritin.

9 plasma lactate deshydrogenase bilirubin, and serum ferritin.

10 l guidelines recommended a concentration for serum ferritin.

11 .747) than for liver T2* (0.514; P<0.001) or serum ferritin (0.518; P<0.001).

12 .948) than for liver T2* (0.589; P<0.001) or serum ferritin (0.629; P<0.001).

13 .42 g/dL; 95% CI: 0.28, 0.56; P < 0.001) and serum ferritin (1.36 mug/L; 95% CI: 1.23, 1.52; P < 0.00

14 sfusion duration, 15 months, average (+/-SD) serum ferritin 2718 plus or minus 1994 ng/mL, and averag

15 hemoglobin (0.1 vs -0.7 g/dL, P < .001) and serum ferritin (41.3 vs 11.3 microg/L, P < .001).

16 concentration (LIC) 20.3 mg Fe/g dry weight, serum ferritin 4417 ng/mL, and cardiac T2* 8.6 ms.

17 by multi-breath-hold MRI T2* and compared to serum ferritin (a traditional marker of iron overload).

18 n immunodiagnostic platform for detection of serum ferritin, a biomarker for iron deficiency, is pres

19 dietary iron bioavailability.Iron intake and serum ferritin, a quantitative marker of body iron store

20 ansport (transferrin saturation) and stores (serum ferritin) among US adults aged > or = 19 y.

21 Serum ferritin and body iron increased early in flight,

22 nts, we measured the inflammatory biomarkers serum ferritin and C-reactive protein (CRP) in 66 patien

23 When patients were stratified based on their serum ferritin and CRP levels, patients with elevation i

24 An inverse relation was observed between serum ferritin and iron absorption from both ferritin an

25 Serum ferritin and iron absorption were inversely correl

26 Relations between serum ferritin and iron intake were investigated by usin

27 rmed a comprehensive analysis of the role of serum ferritin and its genetic determinants in the patho

28 Classically, serum ferritin and liver biopsy have been used to monito

29 Serum ferritin and liver iron concentration are not adeq

30 significant correlation was observed between serum ferritin and liver iron concentration evaluated by

31 ecutive patients with a moderate increase in serum ferritin and liver iron levels who did not carry g

32 osis in thalassemia major and is superior to serum ferritin and liver iron.

33 Deferasirox reduces serum ferritin and LPI in transfusion-dependent patients

34 Patients with Fpn mutation D157G show high serum ferritin and normal to slightly elevated transferr

35 fter adjusting for the acute-phase response, serum ferritin and RBP concentrations were associated wi

36 iron supplementation significantly improved serum ferritin and serum transferrin receptor (sTfR) con

37 Total body iron calculated from serum ferritin and soluble transferrin receptor concentr

38 iron stores (TBI), which are calculated from serum ferritin and soluble transferrin receptor concentr

39 me interactions (P < 0.01) were observed for serum ferritin and soluble transferrin receptor.

40 fect of iron fortification on hemoglobin and serum ferritin and the prevalence of iron deficiency and

41 A poor correlation was observed between serum ferritin and the quantitative iron on liver biopsy

42 ferritin uptake and found that Scara5 bound serum ferritin and then stimulated its endocytosis from

43 Serum ferritin and total-body iron decreased more after

44 nt of body iron based on measurements of the serum ferritin and transferrin receptor was used to exam

45 nts in North America for iron overload using serum ferritin and transferrin saturation measurements a

46 FCM significantly increased serum ferritin and transferrin saturation.

47 ed iron stores, defined as elevation of both serum ferritin and transferrin-iron saturation (TS), in

48 protoporphyrin, transferrin saturation, and serum ferritin) and a low hemoglobin concentration.

49 ber, Shimada histopathologic classification, serum ferritin, and bone marrow immunocytology (sensitiv

50 abnormal values for transferrin saturation, serum ferritin, and erythrocyte protoporphyrin, with the

51 ods results in an improvement in hemoglobin, serum ferritin, and iron nutriture and a reduced risk of

52 ased hemoglobin, transferrin saturation, and serum ferritin, and it significantly reduced serum phosp

53 Patient age, performance status, serum ferritin, and lactate dehydrogenase were significa

54 The transferrin saturation, serum ferritin, and liver iron burden of all PCT patient

55 nescence was positively correlated with HIC, serum ferritin, and oxidative stress.

56 cteristics, cancer, smoking, alcohol intake, serum ferritin, and serum creatinine, low versus normal

57 corpuscular volume, transferrin saturation, serum ferritin, and serum iron.

58 ipuncture for the measurement of hemoglobin, serum ferritin, and serum retinol.

59 Blood was analyzed for hemoglobin, serum ferritin, and serum transferrin receptor.

60 Body iron was determined from hemoglobin, serum ferritin, and transferrin receptor.

61 me (MCV), serum transferrin saturation (TS), serum ferritin, and white blood cell count of African-Am

62 The consensus view is that serum ferritin arises from tissue ferritins--principally

63 ed to label-free assay; capable of measuring serum ferritin as low as 26 ng/mL.

64 With the use of serum ferritin as the indicator, healthy women with repl

65 Liver histopathology and serum ferritin, aspartate aminotransferase, and alanine

66 ths of transfusion (R = 0.795, P <.001), but serum ferritin at biopsy did not correlate with months o

67 Serum ferritin-but not transferrin receptor, transferrin

68 mples by the spot method compared with using serum ferritin by the traditional method in a field sett

69 amin A reduced CRP (by 9.6 mg/L; P = 0.011), serum ferritin (by 18.1 microg/L; P = 0.042), and erythr

70 y in women with BMI (in kg/m(2)) >/=18.5 and serum ferritin concentration </=150 mug/L, although low

71 n predefined success criteria for changes in serum ferritin concentration (all patients) and cardiac

72 The mean serum ferritin concentration among United States dialysi

73 concentration was correlated positively with serum ferritin concentration and negatively with homozyg

74 and the safety measures were mean height and serum ferritin concentration at 3 y.

75 tal weight were maternal height, weight, and serum ferritin concentration at booking, but not haemogl

76 ed all six doses of study drug (n = 57), the serum ferritin concentration increased significantly for

77 KI risk with high-dose deferasirox and lower serum ferritin concentration is consistent with overchel

78 on absorption: Ln absorption, % (adjusted to serum ferritin concentration of 30 microg/L) = 1.9786 +

79 e diagnosis of ID, a cutoff of 100 mug/L for serum ferritin concentration should be considered in mos

80 Iron supplementation increased the serum ferritin concentration significantly, but it had n

81 d progressively increasing mean age-adjusted serum ferritin concentration values in each ethnic group

82 The strongest dietary association with serum ferritin concentration was a positive association

83 In the placental morphology subset, serum ferritin concentration was inversely related to ov

84 Serum ferritin concentration was slightly but significan

85 ption from meals, and models of iron intake, serum ferritin concentration, and iron requirements.We d

86 < 0.001) between red cell radioactivity and serum ferritin concentration.

87 on absorption were inversely associated with serum ferritin concentration.

88 iron deficiency was 9% on the basis of a low serum ferritin concentration.

89 no history of cancer before the survey, and serum ferritin concentrations >/=20 mug/L.

90 Iron absorption was predicted from serum ferritin concentrations and dietary modifiers by u

91 Plasma hepcidin and serum ferritin concentrations are highly correlated, and

92 The World Health Organization recommends serum ferritin concentrations as the best indicator of i

93 BCT affected iron status; serum ferritin concentrations decreased (P < or = 0.05),

94 In individuals with serum ferritin concentrations from 6 to 80 mug/L, predic

95 pendent studies show that only patients with serum ferritin concentrations more than 1000 microg/L ar

96 The model predicted that at serum ferritin concentrations of 15, 30, and 60 mg/L, me

97 estigate the effects of deferasirox dose and serum ferritin concentrations on kidney function and the

98 s well as adult vegetarians often have lower serum ferritin concentrations than omnivores, which is i

99 Serum ferritin concentrations varied across different so

100 akes were 13.6, 10.3, and 10.9 mg/d and mean serum ferritin concentrations were 140.7, 49.4, and 96.7

101 Other factors associated with serum ferritin concentrations were age, body mass index,

102 Serum ferritin concentrations were associated with folat

103 ation Survey (NHANES III), and then the mean serum ferritin concentrations were determined for the tr

104 Serum ferritin concentrations were significantly higher

105 d portable diagnostics for quantification of serum ferritin concentrations, an iron status biomarker,

106 Serum ferritin concentrations, hemoglobin levels, and pe

107 bin, serum iron, transferrin saturation, and serum ferritin concentrations, on consecutive patients r

108 d who were C282Y homozygotes had the highest serum ferritin concentrations.

109 predict dietary iron absorption at different serum ferritin concentrations.

110 e effect of the diet is more marked at lower serum ferritin concentrations.

111 s patients, and an unprecedented increase in serum ferritin concentrations.

112 re treated with either anti-A blood grouping serum, ferritin-conjugated anti-A serum, free ferritin,

113 Serum ferritin correlated inversely with the initial upt

114 Infant serum ferritin decreased (P < 0.0001), serum transferrin

115 Median serum ferritin decreased 23% in the 53% of patients who

116 Similarly, serum ferritin decreased significantly compared with pla

117 In all cohorts, median serum ferritin decreased to < 250 ng/mL.

118 ith normal transferrin saturations, elevated serum ferritins, elevated red cell protoporphyrin IX lev

119 fects of the intervention on iron status for serum ferritin for participants in Italy (P = 0.04) and

120 bsorption was 36 +/- 19% (range: 4-81%), and serum ferritin (geometric x) was 27 microg/L (range: 4-1

121 A serum ferritin greater than 2,000 mug/L predicted death

122 rum ferritin levels (77.8% versus 33.3% with serum ferritin > 300 ng/ml; p = 0.006), and diabetes (44

123 We found that serum ferritin >/= the sex-specific median was one of th

124 Serum ferritin >/=2000 ng/mL and liver iron concentratio

125 s to 10-12 g/dL or normalization (n = 8) and serum ferritin >100 mug/L (n = 7) or 200 mug/L (n = 4).

126 ase), for a liver transplant 14.3 (recipient serum ferritin >500 ug/L), and for a lung transplant 6.3

127 ng/mL) and infants with normal iron status (serum ferritin >75 ng/mL) at birth.

128 The elevation in pre-treatment serum ferritin (>250 ng/ml) or CRP (>7.25 mg/l) was a si

129 Serum ferritin has been used widely in clinical medicine

130 uggestive of hereditary iron deficiency with serum ferritin higher than expected for IDA, mutations i

131 ations of hair zinc in 41.6% of subjects and serum ferritin in 50% were consistent with the presence

132 cardiac and liver T2* magnetic resonance and serum ferritin in 652 thalassemia major patients from 21

133 rphisms in HJV were associated with elevated serum ferritin in HFE C282Y homozygotes.

134 iron, yet bioavailability negligibly affects serum ferritin in longer, controlled trials.

135 investigate differences in concentrations of serum ferritin in patients with and without periodontal

136 also a significantly greater improvement in serum ferritin in the combined group (-976 versus -233 m

137 In the placebo patients, LIC and serum ferritin increased from baseline by 0.38 mg Fe/g d

138 ans (low bone mineral density [BMD], 23.2%), serum ferritin (iron overload, 24.0%), and pulmonary fun

139 Consequently, with the exception of serum ferritin, iron biomarkers are measures of iron suf

140 oderately high levels of three iron markers (serum ferritin, iron, and iron saturation ratio) or admi

141 Depressed serum ferritin is common and provides a useful screening

142 tary iron absorption at any concentration of serum ferritin is presented.

143 Despite the clinical significance of serum ferritin, its secretion remains an enigma.

144 A serum ferritin less than 1000 mug/l in C282Y homozygotes

145 , reticulocyte hemoglobin equivalent >25 pg, serum ferritin level >15 ng/mL, and total iron-binding c

146 the presence of at least 2 of the following: serum ferritin level <12 ng/mL, serum TS level <15%, and

147 ficiency anemia (hemoglobin level <=11 g/dL; serum ferritin level <=100 ng/mL) and intolerance or unr

148 (TS) level (>45%, >50%, and >60%), elevated serum ferritin level (>300, >400, >500, and >600 ng/mL),

149 .026), metastatic disease (P<.001), elevated serum ferritin level (P<.001), unfavorable histopatholog

150 significant correlation was observed between serum ferritin level and cardiac T2* MRI (p = 0.68, r =

151 425 mug/dL at the 12-week visit), changes in serum ferritin level and total iron-binding capacity, ad

152 tected bone marrow disease, MYCN status, and serum ferritin level in bivariate Cox analyses.

153 Median serum ferritin level increased from 3.0 to 15.6 ng/mL (f

154 Only 1 of 93 patients with a serum ferritin level less than 1000 microg/L had cirrhos

155 A serum ferritin level less than 1000 microg/L was predict

156 serum ferritin level of 15 to 100 ng/mL or a serum ferritin level of 101 to 299 ng/mL with transferri

157 rEF (<40%) and iron deficiency, defined as a serum ferritin level of 15 to 100 ng/mL or a serum ferri

158 , the post-treatment degree of change in the serum ferritin level was positively and significantly as

159 An elevated pretransplantation serum ferritin level was strongly associated with lower

160 The 219 children with iron deficiency (serum ferritin level, <22.5 pmol/L [<10 microg/L]) and H

161 on level, serum transferrin-iron saturation, serum ferritin level, and hepatic iron index (P < 0.05).

162 etin prevented the changes in red cell mass, serum ferritin level, and(13)C-heme.

163 decrease was mirrored by a rapid increase in serum ferritin level.

164 2Y homozygotes and 1,367 nonhomozygotes with serum ferritin levels >300 mug/L in men and >200 mug/L i

165 The association between serum ferritin levels >800 ng/ml and mortality in MHD pa

166 nd hepatic outcomes of 1-year maintenance of serum ferritin levels <50 mug/L by bloodletting associat

167 The association between high serum ferritin levels (> median) and the endpoints was a

168 th transferrin saturation > 50%; p = 0.003), serum ferritin levels (77.8% versus 33.3% with serum fer

169 lori infection was associated with decreased serum ferritin levels (percent change = -13.9%, 95% conf

170 Low serum ferritin levels also characterized patients.

171 it during the neonatal period, and increased serum ferritin levels and a lower incidence of iron-defi

172 significant correlation was observed between serum ferritin levels and the number of sites with PD >/

173 In patients with CHC, elevated serum ferritin levels are independently associated with

174 Serum ferritin levels are raised in patients with CP and

175 evealed association between deep pockets and serum ferritin levels at baseline (R(2) = 0.823).

176 To this end, serum ferritin levels at baseline of therapy with pegyla

177 quares mean difference between the groups in serum ferritin levels at week 48 was -348 mug per liter

178 tin doses, and available surrogates of MICS, serum ferritin levels between 200 and 1200 ng/ml (refere

179 r receiving deferasirox for 48 weeks, median serum ferritin levels decreased by 63.5%, 74.8%, and 74.

180 rrhosis compared with 39 of 89 patients with serum ferritin levels greater than 1000 microg/L (P < 0.

181 erum aminotransferase levels (P = 0.001) and serum ferritin levels greater than 1000 microg/L (P = 0.

182 crog/L compared with 72% among patients with serum ferritin levels greater than 1000 microg/L after a

183 We identified 113 patients with serum ferritin levels higher than 50,000 microg/L.

184 Patients with hemochromatosis and serum ferritin levels less than 1000 microg/L are unlike

185 ty of cirrhosis was 7.4% among patients with serum ferritin levels less than 1000 microg/L compared w

186 es or C282Y/H63D compound heterozygotes with serum ferritin levels less than 1000 microg/L had cirrho

187 ong periods of time, excluding subjects with serum ferritin levels less than or equal to 1000 microg/

188 Elevated serum ferritin levels may reflect a systemic inflammator

189 ps/Kaiser hemochromatosis study, only 59 had serum ferritin levels more than 1000 microg/L; 24 had ho

190 were homozygous for the Cys282Tyr mutation, serum ferritin levels of 300-2000 ng/mL, transferrin sat

191 Mean hemoglobin, TSAT, and serum ferritin levels remained higher in the ferric gluc

192 erapy can produce hematologic responses with serum ferritin levels up to 400 microg/L, indicating tha

193 Serum ferritin levels were also independently associated

194 n-Americans were lower than those of whites; serum ferritin levels were higher.

195 In humans, normal-range serum ferritin levels were inversely associated with adi

196 Serum ferritin levels were low in the majority of males

197 Serum ferritin levels were measured in 24 of 32 subjects

198 Significant reductions in serum ferritin levels were observed at the 3-month asses

199 Screening for hemochromatosis with serum ferritin levels will detect the majority of patien

200 ber, Shimada histopathologic classification, serum ferritin levels, and bone marrow immunocytology we

201 Hepcidin excretion correlated well with serum ferritin levels, which are regulated by similar pa

202 etic variations had only a limited impact on serum ferritin levels.

203 ted that expression patterns correlated with serum ferritin levels.

204 laboratory abnormalities, including elevated serum ferritin levels.

205 ansferrin saturation, and other chemistries; serum ferritin levels; and HFE genotype.

206 s model of assessment of insulin resistance, serum ferritin, lipid profile, and liver function tests

207 )-labelled ferrous sulfate in iron-depleted (serum ferritin </=25 mug/L) women aged 18-40 years recru

208 between infants with latent iron deficiency (serum ferritin </=75 ng/mL) and infants with normal iron

209 on <20%, and 47% of women and 44% of men had serum ferritin <100 ng/ml.

210 iron deficiency (ID) by the iron indicators serum ferritin <15 ug/L, serum soluble transferrin recep

211 s who took iron supplements, even those with serum ferritin <21 microg/L (n = 5), adapted to absorb l

212 hemotherapy-related anemia (Hb <or= 105 g/L, serum ferritin <or= 450 pmol/L or <or= 675 pmol/L with t

213 al values for iron measures were as follows: serum ferritin <or=8.7 or <10.0 microg/L, serum transfer

214 The simplified DSS approaches for serum ferritin measurement need to be evaluated further

215 For example, the analytic variability of serum ferritin measurements across laboratories is very

216 lar ejection fraction (LVEF) of 56% or more, serum ferritin more than 2500 ng/mL, liver iron concentr

217 However, unlike serum ferritin, neither serum nor urinary prohepcidin co

218 Among 142 participants, serum ferritin (ng/mL) was associated with apparent DENV

219 ons in hematocrit (P = 0.02), and increasing serum ferritin (P < 0.0001).

220 were observed, whereas time had an effect on serum ferritin (P < or = 0.0001) and hemoglobin (P = 0.0

221 = 0.05) and were positively associated with serum ferritin (P < or = 0.05) and C-reactive protein (P

222 roup were associated with greater changes in serum ferritin (P = 0.01) and body iron (P = 0.01), but

223 Serum ferritin (P = 0.045) and C-reactive protein (P = 0

224 significantly over time [P < 0.0001], as did serum ferritin [P = 0.0003].

225 ors [blood lipids, oxidative stress indexes, serum ferritin, plasma folate, plasma vitamin B-12, and

226 s on admission: elevated C-reactive protein, serum ferritin, procalcitonin, N-terminal pro B-type nat

227 49, P < 0.01) and negatively correlated with serum ferritin (R = -0.39, P < 0.05).

228 on absorption was negatively correlated with serum ferritin (r = -0.59, P < 0.001) and with plasma he

229 Serum hepcidin appropriately correlated with serum ferritin (r = 0.63), reflecting the regulation of

230 Serum ferritin [R(2) = 0.22; beta = -0.17 (95% CI: -0.25

231 Serum prohepcidin correlated directly with serum ferritin (R2 = 0.28, P < 0.01) but was unrelated t

232 unrelated to 59Fe absorption, in contrast to serum ferritin (R2 = 0.33, P < 0.01).

233 condition is typically characterized by high serum ferritin, reduced transferrin saturation, and macr

234 pients (n=169), increased baseline levels of serum ferritin reliably predicted a positive outcome for

235 cept in subjects with low iron stores, whose serum ferritin returned to baseline within 3 mo.

236 ty in TAS was accounted for by baseline TAS, serum ferritin, serum estrone, dietary zinc, and dietary

237 Plasma TAS, serum ferritin, serum iron, transferrin saturation, and

238 Serum ferritin, serum transferrin receptor, and hemoglob

239 ence interval [CI]: 0.03-0.71) together with serum ferritin, serum transferrin, transferrin saturatio

240 of TfR1 was related to midgestation maternal serum ferritin (SF) (beta = -0.32; P = 0.005) and serum

241 ncentrations on estimates of ID according to serum ferritin (SF) (used generically to include plasma

242 ondary outcomes were change from baseline in serum ferritin (SF) and 25-hydroxyvitamin D [25(OH)D], r

243 between race-ethnicity-specific quartiles of serum ferritin (SF) and a set of CVD risk factors [body

244 Because serum ferritin (SF) can be elevated spuriously by inflam

245 Serum ferritin (SF) changes appeared nonlinear compared

246 Serum ferritin (SF) concentrations are the most commonly

247 Most studies used serum ferritin (SF) concentrations as the indicator of i

248 The correction of serum ferritin (SF) concentrations for inflammation beca

249 of iron deficiency (ID) but also have higher serum ferritin (SF) concentrations than those of the gen

250 f reproductive age, median or geometric mean serum ferritin (SF) concentrations were estimated at 26-

251 Serum ferritin (SF) levels are commonly elevated in pati

252 iron replete, and the 97.5th percentile for serum ferritin (SF) was 64.3 mug/L.

253 onship between mobilized iron (mob Fe), age, serum ferritin (SF), and quantitative hepatic iron (QHI)

254 nd urinary hepcidin and their relations with serum ferritin (SF), serum transferrin receptor (sTfR),

255 wk; n = 61) were used to assess hemoglobin, serum ferritin (SF), soluble transferrin receptor (sTfR)

256 trials that assessed effects on hemoglobin, serum ferritin (SF), soluble transferrin receptor, or bo

257 us relies on serum-based indicators, such as serum ferritin (SF), transferrin saturation, and soluble

258 Multiple iron measures, including serum ferritin (SF), transferrin saturation, mean cell v

259 Each data set included measures of serum ferritin (SF), vitamin A, zinc, and CRP measured u

260 mo of age; 2) hemoglobin, hematocrit, iron [serum ferritin (SF)], and zinc status at 12 mo of age; a

261 -two iron-depleted, nonanemic Chinese women [serum ferritin (sFer) <25 mug/L and hemoglobin >110 g/L]

262 cans with elevated saturated transferrin and serum ferritin show higher prevalence of the P47S varian

263 Reduction in serum ferritin significantly correlated with ALT improve

264 In multivariate analysis, only serum ferritin significantly predicted death related to

265 (SMD): -0.30; 95% CI: -0.48, -0.13] but not serum ferritin (SMD: 0.00; 95% CI: -0.7, 0.7).

266 n were assigned to two groups, stratified by serum ferritin so that two groups with similar iron stat

267 hropometry; nutritional biomarkers including serum ferritin, soluble transferrin receptor, retinol-bi

268 was also observed per 250 mug/L decrease in serum ferritin, starting from 1250 mug/L.

269 by the NKF-K/DOQI transferrin saturation or serum ferritin targets.

270 ents with CP showed higher concentrations of serum ferritin than periodontally healthy controls (P <0

271 On the basis of its association with serum ferritin, the initial mucosal uptake was the prima

272 n be derived for any target concentration of serum ferritin, thereby giving risk managers and public

273 re associated with a progressive increase in serum ferritin to 658 ng/ml.

274 Iron parameters (serum iron, serum ferritin, total iron-binding capacity and transfer

275 ping and association studies for serum iron, serum ferritin, transferrin saturation (SAT) and total i

276 ategy controlled study-wise type 1 error for serum ferritin, transferrin saturation, and intravenous

277 d in blood indexes of iron status (including serum ferritin, transferrin saturation, and non-transfer

278 Measurement of serum ferritin, transferrin saturation, serum soluble tr

279 ns should closely monitor renal function and serum ferritin, use the lowest effective dose to maintai

280 values correlated strongly with traditional serum ferritin values (r = 0.88 and 0.86, respectively;

281 +/- 9.4 microg/L higher, respectively, than serum ferritin values obtained with the traditional meth

282 treatment (P <0.01), and the post-treatment serum ferritin values were comparable to those of contro

283 The mean corpuscular volume (MCV) and serum ferritin values were significantly lower in H. pyl

284 Phlebotomies were performed when serum ferritin was > 100 mug/L.

285 The mean serum ferritin was 185 (+/- 99) mug/L.

286 omol/g and 41.6% were < or =1.68 micromol/g; serum ferritin was 25.7 +/- 18.6 microg/L and 50.0% were

287 fter treatment, a significant improvement in serum ferritin was associated with a 5-7-fold improvemen

288 nstitution, and on whom a pretransplantation serum ferritin was available.

289 Her serum ferritin was higher than 21,000 ng/mL and transfer

290 Serum ferritin was insensitive to diet but fecal ferriti

291 sk (4.47, 1.25-15.95, p=0.0209) for AKI when serum ferritin was less than 1000 mug/L.

292 n in all other groups at ages 4 and 5 mo and serum ferritin was lower in the RTF-12 group than in the

293 errin receptor were elevated (P < 0.05), and serum ferritin was lowered (P < 0.05) post-BCT.

294 Serum ferritin was negatively associated with serum lept

295 Serum ferritin was not associated with cancer risk or ca

296 Serum ferritin was positively correlated with the oxidat

297 Serum ferritin was significantly higher in the iron-supp

298 s well as a genome-wide association study of serum ferritin were performed.

299 ll sources was strongly inversely related to serum ferritin, with geometric means of 32.5% (iron asco

300 -d food diary was completed, and hemoglobin, serum ferritin, zinc, copper, and C-reactive protein con